3Schomig A. Catecholamines in myocardial ischemia. Systemic and cardiac release. Circulation, 1990, 82: 13-22.
4Waldenstrom AP, Hjahnarson AC, Thornell L. A possible role of noradrenaline in the development of myocardial infarction : an experimental study in the isolated rat heart. Am Heart J, 1978, 95: 43-51.
5Pernow B. Substance P. Pharmarcol Rev, 1983, 35: 85-141.
6Ustinova EE, Bergren D, Sehuhz HD. Neuropeptide depletion impairs postischemic recovery of the isolated rat heart: role of substance P. Cardiovasc Res, 1995, 30: 55-63.
7Hoover DB. Effects of substance P on rate and perfusion pressure in the isolated guinea pig heart. J Pharmacol Exp Ther, 1990, 252: 179-184.
8Wharton J, Polak JM, McGregor GP, et al. The distribution of substance P-like immunoreactive nervers in the guinea-pig heart. Neuroscience, 1981, 6: 2193-2204.
9Weihe E, Reinecke M, Opherk D, et al. Peptidergic innervation (substance P) in the human heart. J Mol Cell Cardiol, 1981, 13: 331-333.
10Hoover DB, Hancock JC. Distribution of substance P binding sites in guinea-pig heart and pharmacological effects of substance P. J Auton Nerv Syst, 1988, 23: 189-197.
